financetom
Business
financetom
/
Business
/
Pitney Bowes' Q1 Adjusted Earnings Increase, Revenue Declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pitney Bowes' Q1 Adjusted Earnings Increase, Revenue Declines
May 26, 2025 3:51 AM

05:05 AM EDT, 05/08/2025 (MT Newswires) -- Pitney Bowes ( PBI ) reported Q1 adjusted earnings late Wednesday of $0.33 per diluted share, up from $0.19 a year earlier.

Two analysts polled by FactSet expected $0.27.

Revenue for the quarter ended March 31 was $493.4 million, compared with $521.3 million a year earlier.

An analyst polled by FactSet expected $497.9 million.

The company reiterated its 2025 guidance of $1.10 to $1.30 in adjusted EPS on $1.95 billion to $2 billion in revenue. Analysts polled by FactSet expect $1.20 in adjusted EPS on revenue of $1.98 billion.

Pitney Bowes ( PBI ) also said it raised its quarterly dividend to $0.07 per share, from $0.06 previously, payable June 6 to shareholders as of May 19.

Shares of Pitney Bowes ( PBI ) were up over 5% in premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EV maker Rivian may report first quarterly revenue drop since IPO
EV maker Rivian may report first quarterly revenue drop since IPO
Nov 9, 2024
(Reuters) - Rivian is expected to report on Thursday its first drop in quarterly revenue since going public three years ago, after a shortage of parts forced the maker of electric SUVs and pickups to slash its 2024 production target last month. CEO RJ Scaringe will likely face tough questions from analysts and investors on how long the shortage is...
Novo Nordisk says its experimental drug CagriSema has similar side effects to Wegovy
Novo Nordisk says its experimental drug CagriSema has similar side effects to Wegovy
Nov 9, 2024
LONDON, Nov 6 (Reuters) - Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 drugs already on the market, and reiterated its expectation the new injection will deliver 25% weight loss. Martin Holst Lange, Novo Nordisk's head of development, made the comments to Reuters in an interview after...
Triple Flag Precious Metals' Q3 Adjusted Net Earnings, Revenue Rise
Triple Flag Precious Metals' Q3 Adjusted Net Earnings, Revenue Rise
Nov 9, 2024
05:58 AM EST, 11/06/2024 (MT Newswires) -- Triple Flag Precious Metals ( TFPM ) reported Q3 adjusted net earnings late Tuesday of $0.15 per share, up from $0.10 a year earlier. Analysts polled by Capital IQ expected $0.14. Revenue for the quarter ended Sept. 30 was $73.7 million, up from $49.4 million a year earlier. Two analysts surveyed by Capital...
China's cheap Iranian oil supply at risk from tighter Trump sanctions
China's cheap Iranian oil supply at risk from tighter Trump sanctions
Nov 9, 2024
By Chen Aizhu and Siyi Liu SINGAPORE (Reuters) - China faces a squeeze on supplies of cheap Iranian crude, which make up about 13% of imports by the world's biggest buyer of oil, if Donald Trump ramps up enforcement of sanctions on Tehran after his return as U.S. president in January. Trump, who won Tuesday's election, Edison Research projected, is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved